Insights

Expanded reagent portfolio KPL offers a broad catalog of over 800 reagents and kits for immunoassays, immunohistochemistry, infectivity assays and flow cytometry, presenting multiple cross-selling opportunities across diagnostic and research workflows.

Specialized pathogen reagents The BacTrace native antigens and polyclonal antibodies for bacterial pathogens provide unique differentiation for customers needing high-sensitivity pathogen detection, enabling targeted upsell into infectious disease and clinical microbiology markets.

Quality and standards focus AccuPlex and AccuSet quality solutions for SARS-CoV-2 and HEV reference materials demonstrate a strong emphasis on assay validation, offering sales angles around regulatory compliance, method verification, and quality control programs.

Digital and analytics backbone Active use of LinkedIn Ads, Microsoft Advertising, HubSpot Analytics and other tech stack elements signals readiness for account-based marketing, intent data, and personalized outreach to larger labs and contract research organizations.

Growth via new controls Recent launches of ACCURUN Babesia Positive Molecular Control Kit and expansion of SARS-CoV-2 quality controls indicate ongoing product line refreshes, suggesting opportunities for add-on controls, panels, and companion products during assay development and verification cycles.

Similar companies to KPL (Part of LGC Clinical Diagnostics)

KPL (Part of LGC Clinical Diagnostics) Tech Stack

KPL (Part of LGC Clinical Diagnostics) uses 8 technology products and services including LinkedIn Ads, Microsoft Advertising, HubSpot Analytics, and more. Explore KPL (Part of LGC Clinical Diagnostics)'s tech stack below.

Media & News

KPL (Part of LGC Clinical Diagnostics)'s Email Address Formats

KPL (Part of LGC Clinical Diagnostics) uses at least 6 email formats:
KPL (Part of LGC Clinical Diagnostics) Email FormatsExamplePercentage
FLast@kpl.comJDoe@kpl.com
82%
First.Last@kpl.comJohn.Doe@kpl.com
18%
FLast@seracare.comJDoe@seracare.com
93%
FirstLast@seracare.comJohnDoe@seracare.com
5%
Last@seracare.comDoe@seracare.com
1%
First_Last@seracare.comJohn_Doe@seracare.com
1%

Frequently Asked Questions

What is KPL (Part of LGC Clinical Diagnostics)'s stock symbol?

Minus sign iconPlus sign icon
KPL (Part of LGC Clinical Diagnostics) is a publicly traded company; the company's stock symbol is KPLT.

What is KPL (Part of LGC Clinical Diagnostics)'s official website and social media links?

Minus sign iconPlus sign icon
KPL (Part of LGC Clinical Diagnostics)'s official website is seracare.com and has social profiles on LinkedIn.

How much revenue does KPL (Part of LGC Clinical Diagnostics) generate?

Minus sign iconPlus sign icon
As of October 2026, KPL (Part of LGC Clinical Diagnostics)'s annual revenue is estimated to be $250M - $500M.

What is KPL (Part of LGC Clinical Diagnostics)'s SIC code and NAICS code?

Minus sign iconPlus sign icon
KPL (Part of LGC Clinical Diagnostics)'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does KPL (Part of LGC Clinical Diagnostics) have currently?

Minus sign iconPlus sign icon
As of October 2026, KPL (Part of LGC Clinical Diagnostics) has approximately 182 employees across 6 continents, including North America, Europe and Asia. Key team members include Chief Executive Officer: B. S., Head Of Software Engineering: H. R. and Director Corporate Accounts: L. L. Explore KPL (Part of LGC Clinical Diagnostics)'s employee directory with LeadIQ.

What industry does KPL (Part of LGC Clinical Diagnostics) belong to?

Minus sign iconPlus sign icon
KPL (Part of LGC Clinical Diagnostics) operates in the Biotechnology Research industry.

What technology does KPL (Part of LGC Clinical Diagnostics) use?

Minus sign iconPlus sign icon
KPL (Part of LGC Clinical Diagnostics)'s tech stack includes LinkedIn Ads, Microsoft Advertising, HubSpot Analytics, Microsoft Clarity, Mimecast, Agentforce, Microsoft Azure and Piwik PRO Core.

What is KPL (Part of LGC Clinical Diagnostics)'s email format?

Minus sign iconPlus sign icon
KPL (Part of LGC Clinical Diagnostics)'s email format typically follows the pattern of FLast@kpl.com. Find more KPL (Part of LGC Clinical Diagnostics) email formats with LeadIQ.

When was KPL (Part of LGC Clinical Diagnostics) founded?

Minus sign iconPlus sign icon
KPL (Part of LGC Clinical Diagnostics) was founded in 1986.
KPL (Part of LGC Clinical Diagnostics) logo

KPL (Part of LGC Clinical Diagnostics)

Biotechnology ResearchMaryland, United States51-200 Employees

KPL is a portfolio within LGC Clinical Diagnostics that operates in the biotechnology research sector, offering more than 800 reagents and kits for immunoassays, immunohistochemistry, infectivity assays, and flow cytometry. Its product line includes the BacTrace range of native bacterial antigens and polyclonal antibodies, as well as secondary antibodies, substrates, and washing buffers. These reagents are designed to maximize signal-to-noise ratios, supporting sensitivity and specificity across diverse applications.

Based in Gaithersburg, Maryland, the company is part of LGC's Clinical Diagnostics organization. Its customers are researchers and diagnostic developers in biotechnology and related life-science fields who rely on reagents for assay development and validation. A recent development includes the December 2023 launch of the ACCURUN Babesia Positive Molecular Control Kit.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
KPLT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1986
Employees
51-200

Section iconFunding & Financials

  • $250M - $500M

    KPL (Part of LGC Clinical Diagnostics)'s revenue is estimated to be in the range of $250M - $500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.